Benefit of Moderate Intensity Exercise in Patients With Clinical Quiescent Inflammatory Bowel Disease
Not applicable · Testing Exercise · 1 site · Mahidol University
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing Exercise (a behavioral program) to see if it can prevent disease or complications. Condition(s) listed: Inflammatory Bowel Disease (IBD).
Participants are assigned to groups by chance (randomized).
It is blinded: participants and the study team do not know who receives what.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 to 65
- Any sex
Some of the main requirements, copied from the record:
- Patients diagnosed with Crohn's disease or Ulcerative colitis.
- Aged between 18 and 65 years.
- Disease must be in clinical remission for at least 2 months prior to study enrollment, as defined by: Crohn's disease: Harvey-Bradshaw Index < 5 Ulcerative colitis: Mayo Ulcerative Colitis Subscore < 2
Plus 3 more requirement(s). There are also 6 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 50 participants are expected to take part.
- Start date: 2024-11-17.
- Main results expected around 2026-12-31 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Thailand.
Main thing being measured
- Short Inflammatory Bowel Disease Questionnaire (SIBDQ) (6 months)
In the researchers’ words
The goal of this Randomised controlled trial is to investigate the effect of exercise on changes in quality of life in in patients with clinical quiescent Inflammatory bowel Disease. The main question it aims to answer * The Relationship Between Moderate-Intensity Exercise and Quality of Life in Patients with clinical quiescent nflammatory Bowel Disease Over a Six-Month Period * To examine the association between…
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Inflammatory Bowel Disease (IBD) |
| Lead sponsor | Mahidol University |
| Enrollment | 50 (estimated) |
| Start date | 2024-11-17 |
| Primary completion (est.) | 2026-12-31 |
| First posted | 2026-08-20 |
| Last updated | 2026-08-20 |
| Official title | Benefit of Moderate Intensity Exercise in Patients With Clinical Quiescent Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT07775794 |
Interventions
- Exercise (Behavioral)
Patient will be encouraged in moderate-intensity exercise for at least 30 minutes per session, three times per week or more, under the supervision and guidance of a sports scientist. To look for improvement of IPAQ score
Full eligibility criteria (from the record)
Inclusion Criteria: * Patients diagnosed with Crohn's disease or Ulcerative colitis. * Aged between 18 and 65 years. * Disease must be in clinical remission for at least 2 months prior to study enrollment, as defined by: Crohn's disease: Harvey-Bradshaw Index < 5 Ulcerative colitis: Mayo Ulcerative Colitis Subscore < 2 * Not currently receiving corticosteroids, * If receiving immunomodulators or biologic therapy, the treatment regimen must be stable for at least 2 months prior to enrollment. * Participants must have access to and be capable of using online communication tools and digital platforms. Exclusion Criteria: * Patients with medical conditions that limit the ability to exercise, including Severe joint pain or inflammatory arthritis affecting ambulation or mobility Advanced cardiac disease (New York Heart Association Class ≥ 2) Chronic lung disease or pulmonary hypertension Liver cirrhosis Chronic kidney disease stage 3 or higher Poorly controlled non-communicable diseases, such as: Hypertension (BP ≥ 160/100 mmHg) Diabetes mellitus with poor glycemic control (HbA1c ≥ 9% or requiring insulin therapy) * Patients who already engage in moderate-intensity exercise for more than 60 minutes per week on a regular basis. * Pregnant individuals or those planning to become pregnant during the study period. * Patients planning to undergo treatment changes or surgery within the next 3 months, or who have had surgery within the past 6 months.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of Medicine Siriraj Hospital | Bangkok Noi, Bangkok | Thailand | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.